Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-Cyclopentene-1-carboxylic acid ethyl ester, also known as ethyl 3-cyclopentene-1-carboxylate, is a colorless liquid chemical compound with the molecular formula C9H14O2. It is an ester formed by the condensation reaction of 3-cyclopentene-1-carboxylic acid with ethanol. 3-Cyclopentene-1-carboxylic acid ethyl ester is relatively stable under normal conditions but requires careful handling and storage to avoid potential hazards from violent reactions with strong oxidizing agents and strong acids.

21622-01-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 21622-01-5 Structure
  • Basic information

    1. Product Name: 3-Cyclopentene-1-carboxylic acid ethyl ester
    2. Synonyms: ETHYL 3-CYCLOPENTENECARBOXYLATE;3-CYCLOPENTENECARBOXYLIC ACID ETHYL ESTER;ethyl cyclopent-3-enecarboxylate;3-cyclopentene-1-carhoxylic acid ethyl ester;ETHYL 3-CYCLOPENTENE-1-CARBOXYLATE;3-Cyclopentene-1-carboxylic acid ethyl ester;Ethyl 3-cyclopentenecarboxylic acid
    3. CAS NO:21622-01-5
    4. Molecular Formula: C8H12O2
    5. Molecular Weight: 140.18
    6. EINECS: N/A
    7. Product Categories: INTERMEDIATESOFDOLASETRONMESYLATE
    8. Mol File: 21622-01-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 64°C/15mmHg(lit.)
    3. Flash Point: 48.2 °C
    4. Appearance: /
    5. Density: 1.029 g/cm3
    6. Vapor Pressure: 1.31mmHg at 25°C
    7. Refractive Index: 1.4460-1.4500
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: 3-Cyclopentene-1-carboxylic acid ethyl ester(CAS DataBase Reference)
    11. NIST Chemistry Reference: 3-Cyclopentene-1-carboxylic acid ethyl ester(21622-01-5)
    12. EPA Substance Registry System: 3-Cyclopentene-1-carboxylic acid ethyl ester(21622-01-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. RIDADR: 3272
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 3
    8. PackingGroup: III
    9. Hazardous Substances Data: 21622-01-5(Hazardous Substances Data)

21622-01-5 Usage

Uses

Used in the Food and Beverage Industry:
3-Cyclopentene-1-carboxylic acid ethyl ester is used as a flavoring agent for its ability to impart specific tastes and aromas to various food and beverage products, enhancing their overall sensory appeal.
Used in the Cosmetic Industry:
In the cosmetic industry, 3-Cyclopentene-1-carboxylic acid ethyl ester is utilized as a fragrance ingredient, contributing to the creation of pleasant and desirable scents in cosmetic products.
Used in Pharmaceutical Synthesis:
3-Cyclopentene-1-carboxylic acid ethyl ester is employed as a key intermediate in the synthesis of various pharmaceutical compounds, playing a crucial role in the development of new drugs.
Used in Agrochemical Synthesis:
3-Cyclopentene-1-carboxylic acid ethyl ester is also used in the synthesis of agrochemicals, where it serves as a building block for the development of products that contribute to agricultural productivity and pest control.

Check Digit Verification of cas no

The CAS Registry Mumber 21622-01-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,6,2 and 2 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 21622-01:
(7*2)+(6*1)+(5*6)+(4*2)+(3*2)+(2*0)+(1*1)=65
65 % 10 = 5
So 21622-01-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H12O2/c1-2-10-8(9)7-5-3-4-6-7/h3-4,7H,2,5-6H2,1H3

21622-01-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name ethyl cyclopent-3-ene-1-carboxylate

1.2 Other means of identification

Product number -
Other names Ethyl 3-cyclopentenecarboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21622-01-5 SDS

21622-01-5Relevant articles and documents

New synthesis of 3-cyclopentenecarboxylic acid esters by olefin metathesis

Bespalova, N. B.,Bovina, M. A.,Sergeeva, M. B.,Zaikin, V. G.

, p. 1425 - 1426 (1994)

Olefin metathesis of diallylacetic acid esters is proposed for the synthesis of 3-cyclopentenecarboxylic acid esters.WCl6-organosilicon compounds are used as homogeneous catalysts. - Key words: olefin metathesis, 3-cyclopentenecarboxylic acid esters, homogeneous silicon-containing catalysts.

Practical and Scalable Synthesis of a Glucokinase Activator via One-Pot Difluorination and Julia Olefination

Inoshita, Yasuo,Iwamoto, Minoru,Koyama, Yuzo,Kumamoto, Takuya,Miyamoto, Hidetoshi,Sakumoto, Chihiro,Sato, Yoshinori,Tamamizu, Tokihiko,Tsuchiya, Hideyoshi

, p. 1294 - 1303 (2020/08/14)

We describe the process research and development of a practical synthesis of glucokinase activator 1 as a potential drug for treating type 2 diabetes mellitus. The key structure, a 3,4-cis-difluorinated cyclopentane moiety, was constructed via diastereoselective epoxidation, followed by one-pot difluorination with Et3N·3HF and perfluorobutanesulfonyl fluoride (PBSF). Julia olefination of benzothiazol-2-yl sulfone with glyoxylate furnished an E/Z mixture of acrylate, followed by isomerization of the alkene to the desired E configuration during the formation of the acid chloride in the final step. This development achieved a highly practical process route to 1 (15percent overall yield, 12 steps). This process route overcomes the drawbacks of the original medicinal chemistry synthetic route, which used hazardous and costly reagents (LiAlH4, OsO4, and Deoxo-Fluor) and had low efficiency (4percent overall yield, 20 steps).

Molybdenum Benzylidyne Complexes for Olefin Metathesis Reactions

Acosta, Carlos M.,Bukhryakov, Konstantin V.,Chuprun, Sergey,Mathivathanan, Logesh

supporting information, p. 3453 - 3457 (2020/11/02)

The molybdenum benzylidynes [ArCMo(OC(CF3)2CH3)3(1,2-dimethoxyethane)], where Ar = Ph (2a), p-(OCH3)C6H4 (2b), p-(CF3)C6H4 (2c), p-(NO2)C6H4 (2d), or 4-(NO2)-3-(CF3)C6H3 (2e), and [p-(NO2)C6H4CMo(OC(CF3)2CH3)3] (2f) catalyze the ring-closing metathesis (RCM) reaction of diallyl N-tosylamide (3) to produce 1-tosyl-2,5-dihydro-1H-pyrrole (4) and ethylene. The scope of RCM catalytic activity of 2e, cross-metathesis of 1-hexene, and ring-opening metathesis polymerization of cyclooctene were explored. The X-ray crystal structure of 2e was determined. Variable-temperature 1H NMR spectra revealed the formation of intermediates during the reaction of 3 with 2f and the reforming of 2f after completion of the reaction. The use of 13C-labeled Mo benzylidyne did not show transfer of the carbon atom next to Mo to any of the products.

SUBSTITUTED CYCLOPENTANE-AMIDES FOR TREATING DISORDERS RELATED TO RET

-

Paragraph 00206; 00207; 00208, (2018/03/01)

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

2′-fluoronucleosides

-

Page/Page column 57; 58, (2015/11/30)

2′-Fluoro-nucleoside compounds are disclosed which are useful in the treatment of hepatitis B infection, hepatitis C infection, HIV and abnormal cellular proliferation, including tumors and cancer. The compounds have the general formulae: wherein Base is a purine or pyrimidine base;R1 is OH, H, OR3, N3, CN, halogen, CF3, lower alkyl, amino, loweralkylamino, di(lower)alkylamino, or alkoxy;R2 is H, phosphate, or a stabilized phosphate prodrug; acyl, or other pharmaceutically acceptable leaving benzyl, a lipid, an amino acid, peptide, or cholesterol; andR3 is acyl, alkyl, phosphate, or other pharmaceutically acceptable leaving group; or a pharmaceutically acceptable salt thereof.

A broadly applicable and practical oligomeric (salen)Co catalyst for enantioselective epoxide ring-opening reactions

White, David E.,Tadross, Pamela M.,Lu, Zhe,Jacobsen, Eric N.

, p. 4165 - 4180 (2014/06/09)

The (salen)Co catalyst (4a) can be prepared as a mixture of cyclic oligomers in a short, chromatography-free synthesis from inexpensive, commercially available precursors. This catalyst displays remarkable enhancements in reactivity and enantioselectivity relative to monomeric and other multimeric (salen)Co catalysts in a wide variety of enantioselective epoxide ring-opening reactions. The application of catalyst 4a is illustrated in the kinetic resolution of terminal epoxides by nucleophilic ring-opening with water, phenols, and primary alcohols; the desymmetrization of meso epoxides by addition of water and carbamates; and the desymmetrization of oxetanes by intramolecular ring opening with alcohols and phenols. The favorable solubility properties of complex 4a under the catalytic conditions facilitated mechanistic studies, allowing elucidation of the basis for the beneficial effect of oligomerization. Finally, a catalyst selection guide is provided to delineate the specific advantages of oligomeric catalyst 4a relative to (salen)Co monomer 1 for each reaction class.

Desymmetrization of cyclic olefins via asymmetric Heck reaction and hydroarylation

Liu, Sijia,Zhou, Jianrong

supporting information, p. 11758 - 11760 (2013/12/04)

An asymmetric Heck reaction allows desymmetrization of substituted cyclic olefins in high dr and ee. A bisphosphine oxide is uniquely stereoselective for this purpose. Desymmetrization of bicyclic olefins via hydroarylation can also be realized in high ee.

SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

-

Page/Page column 200, (2012/11/07)

Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.

Combination of olefin metathesis and enzymatic ester hydrolysis in aqueous media in a one-pot synthesis

Tenbrink, Katharina,Sessler, Miriam,Schatz, Juergen,Groeger, Harald

scheme or table, p. 2363 - 2367 (2011/10/13)

A new synthetic method for the preparation of cyclic malonic acid monoesters in aqueous media was developed based on the combination of a metathesis reaction and subsequent biocatalytic hydrolysis with a pig liver esterase in a one-pot synthesis. Both reaction steps proceed smoothly under optimized conditions in aqueous media requiring only a low amount of the metal catalyst for the metathesis reaction. Notably, the applied biocatalyst turned out to be highly compatible with the metal catalyst showing no significant influence on the enzyme activity. Copyright

Polymorphic Forms of Dolasetron Base and Processes of Preparing Dolasetron Base, Its Polymorphic Forms and Salt Thereof

-

Page/Page column 10, (2008/12/08)

The present disclosure relates to a process for the preparation of endo-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one or Dolasetron base. It also discloses a process for the preparation of endo-hexahydro-8-(3-indolylcarbonyloxy)-2,6-methano-2H-quinolizin-3(4H)-one mesylate or Dolasetron mesylate. Further, the present disclosure relates to a process for producing Form I of Dolasetron base, and to the novel crystalline polymorphs, Form II, III, IV and V of Dolasetron base and industrial processes for producing them.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21622-01-5